Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Exelixis, Inc. - Common Stock (NQ:EXEL)

47.27 +2.62 (+5.87%)
Streaming Delayed Price Updated: 2:33 PM EDT, May 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,891,422
Open 44.55
Bid (Size) 47.25 (1)
Ask (Size) 47.29 (1)
Prev. Close 44.65
Today's Range 44.21 - 48.85
52wk Range 20.14 - 45.29
Shares Outstanding 315,048,788
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Demystifying Exelixis: Insights From 8 Analyst Reviews
Via Benzinga
Exelixis Stock Soars As Analysts Applaud Raised 2025 Guidance, Q1 Earnings Beat
Exelixis lifts 2025 revenue outlook after strong Q1 driven by Cabometyx sales surge and early traction in the neuroendocrine tumor market. 
Via Benzinga

Performance

YTD
+39.3%
+39.3%
1 Month
+32.3%
+32.3%
3 Month
+44.1%
+44.1%
6 Month
+34.3%
+34.3%
1 Year
+125.2%
+125.2%

More News

Read More
Tech Stocks Edge Up, AMD Rallies 5%, 30-Year Yields Eye Danger Zone: What's Driving Markets Wednesday?
Via Benzinga
Why Exelixis Stock Is Skyrocketing Today
Via The Motley Fool
Exploring Exelixis's Earnings Expectations
Via Benzinga
Is the Market Bullish or Bearish on Exelixis?
Via Benzinga
Exelixis Crushes Q1 Earnings Estimates With Strong Cabometyx Sales, Raises 2025 Revenue Guidance
Via Benzinga
Biotech Leader Exelixis Pops After Obliterating First-Quarter Profit Expectations
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Exelixis Announces First Quarter 2025 Financial Results and Provides Corporate Update
From Exelixis, Inc.
Via Business Wire
Exelixis to Webcast Fireside Chats as Part of Investor Conferences in May
From Exelixis, Inc.
Via Business Wire
Earnings Scheduled For May 13, 2025
Via Benzinga
EXELIXIS INC (NASDAQ:EXEL) – A Strong Minervini Trend Template Candidate
Via Chartmill
Exelixis to Release First Quarter 2025 Financial Results on Tuesday, May 13, 2025
From Exelixis, Inc.
Via Business Wire
For those who appreciate growth without the sticker shock, EXELIXIS INC (NASDAQ:EXEL) is worth considering.
Via Chartmill
Does EXELIXIS INC (NASDAQ:EXEL) align with Mark Minervini’s trading strategy?
Via Chartmill
Expert Outlook: Exelixis Through The Eyes Of 19 Analysts
Via Benzinga
Why EXELIXIS INC (NASDAQ:EXEL) is Poised for High Growth.
Via Chartmill
EXELIXIS INC (NASDAQ:EXEL) qualifies as a high growth stock and is consolidating.
Via Chartmill
For those who appreciate growth without the sticker shock, EXELIXIS INC (NASDAQ:EXEL) is worth considering.
Via Chartmill
EXELIXIS INC (NASDAQ:EXEL) stands out as a stock that provides good value for the fundamentals it showcases.
Via Chartmill
The Smartest Biotech Stocks to Buy With $50
Via The Motley Fool
FDA Approves Exelixis' Lead Cancer Drug Cabometyx For Expanded Use In Neuroendocrine Tumors
Via Benzinga
Exposures Product Safety
Exelixis Announces U.S. FDA Approval of CABOMETYX® (cabozantinib) for Patients with Previously Treated Advanced Neuroendocrine Tumors
From Exelixis, Inc.
Via Business Wire
Exelixis to Present Positive Preclinical Data Across Its Pipeline Portfolio for Advanced Cancers at AACR 2025
From Exelixis, Inc.
Via Business Wire
Looking Into Exelixis's Recent Short Interest
Via Benzinga

Frequently Asked Questions

Is Exelixis, Inc. - Common Stock publicly traded?
Yes, Exelixis, Inc. - Common Stock is publicly traded.
What exchange does Exelixis, Inc. - Common Stock trade on?
Exelixis, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Exelixis, Inc. - Common Stock?
The ticker symbol for Exelixis, Inc. - Common Stock is EXEL on the Nasdaq Stock Market
What is the current price of Exelixis, Inc. - Common Stock?
The current price of Exelixis, Inc. - Common Stock is 47.27
When was Exelixis, Inc. - Common Stock last traded?
The last trade of Exelixis, Inc. - Common Stock was at 05/15/25 02:33 PM ET
What is the market capitalization of Exelixis, Inc. - Common Stock?
The market capitalization of Exelixis, Inc. - Common Stock is 14.89B
How many shares of Exelixis, Inc. - Common Stock are outstanding?
Exelixis, Inc. - Common Stock has 15B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.